Measuring motivation for medical treatment: confirming the factor structure of the Achievement Motivation Index for Medical Treatment (AMI-MeT)

por Hatta, Taichi, Naria, Keiichi, Yanagihara, Kazuhiro, Ishiguro, Hiroshi, Murayama, Toshinori, Yokode, Masayuki
Publicado 2016

Erratum to: Measuring motivation for medical treatment: confirming the factor structure of the Achievement Motivation Index for Medical Treatment (AMI-MeT)

por Hatta, Taichi, Narita, Keiichi, Yanagihara, Kazuhiro, Ishiguro, Hiroshi, Murayama, Toshinori, Yokode, Masayuki
Publicado 2016

Design paper: A phase II study of Bevacizumab and Erlotinib in patients with non-Squamous non-small cell lung cancer that is refractory or relapsed after 1-2 previous Treatment (BE...

por Tanaka, Shiro, Sakamori, Yuichi, Niimi, Miyuki, Hazama, Megumi, Kim, Young H, Yanagihara, Kazuhiro
Publicado 2011

Expression of Thymidylate Synthase in Human Non‐small Cell Lung Cancer

por Otake, Yosuke, Tanaka, Fumihiro, Yanagihara, Kazuhiro, Hitomi, Shigeki, Okabe, Hiroyuki, Fukushima, Masakazu, Wada, Hiromi
Publicado 1999

p53 Status Predicts the Efficacy of Postoperative Oral Administration of Tegafur for Completely Resected Non‐small Cell Lung Cancer

por Tanaka, Fumihiro, Yanagihara, Kazuhiro, Ohtake, Yohsuke, Miyahara, Ryou, Kawano, Youzou, Fukuse, Tatsuo, Hitomi, Shigeki, Wada, Hiromi
Publicado 1999

The reversal of recurrence hazard rate between ER positive and negative breast cancer patients with axillary lymph node dissection (pathological stage I-III) 3 years after surgery

por Kiba, Takayoshi, Inamoto, Takashi, Nishimura, Tsutomu, Ueno, Masaya, Yanagihara, Kazuhiro, Teramukai, Satoshi, Kato, Hironori, Toi, Masakazu, Fukushima, Masanori
Publicado 2008

Interstitial lung disease in gefitinib-treated Japanese patients with non-small cell lung cancer – a retrospective analysis: JMTO LC03-02

por Nakagawa, Masatsugu, Nishimura, Tsutomu, Teramukai, Satoshi, Tada, Harue, Tanaka, Fumihiro, Yanagihara, Kazuhiro, Furuse, Kiyoyuki, Wada, Hiromi, Fukushima, Masanori
Publicado 2009

Development the Care Evaluation Scale Version 2.0: a modified version of a measure for bereaved family members to evaluate the structure and process of palliative care for cancer p...

por Miyashita, Mitsunori, Aoyama, Maho, Nakahata, Misato, Yamada, Yuji, Abe, Mutsumi, Yanagihara, Kazuhiro, Shirado, Akemi, Shutoh, Mariko, Okamoto, Yoshiaki, Hamano, Jun, Miyamoto, Aoi, Yoshida, Saki, Sato, Kazuki, Hirai, Kei, Morita, Tatsuya
Publicado 2017

Efficacy of the eribulin, pertuzumab, and trastuzumab combination therapy for human epidermal growth factor receptor 2–positive advanced or metastatic breast cancer: a multicenter,...

por Yamashita, Toshinari, Kawaguchi, Hidetoshi, Masuda, Norikazu, Kitada, Masahiro, Narui, Kazutaka, Hattori, Masaya, Yoshinami, Tetsuhiro, Matsunami, Nobuki, Yanagihara, Kazuhiro, Kawasoe, Teru, Nagashima, Takeshi, Bando, Hiroko, Yano, Hiroshi, Hasegawa, Yoshie, Nakamura, Rikiya, Kashiwaba, Masahiro, Morita, Satoshi, Ohno, Shinji, Toi, Masakazu
Publicado 2020

A double‐blind, randomized, multicenter phase 3 study of palonosetron vs granisetron combined with dexamethasone and fosaprepitant to prevent chemotherapy‐induced nausea and vomiti...

por Matsumoto, Koji, Takahashi, Masato, Sato, Kazuhiko, Osaki, Akihiko, Takano, Toshimi, Naito, Yoichi, Matsuura, Kazuo, Aogi, Kenjiro, Fujiwara, Kimiko, Tamura, Kenji, Baba, Motoi, Tokunaga, Shinya, Hirano, Gen, Imoto, Shigeru, Miyazaki, Chieko, Yanagihara, Kazuhiro, Imamura, Chiyo K., Chiba, Yasutaka, Saeki, Toshiaki
Publicado 2020

The Phase II Study of Panitumumab in Chemotherapy-Naïve Frail or Elderly Patients with RAS Wild-type Colorectal Cancer: OGSG 1602 Final Results

por Terazawa, Tetsuji, Kato, Takeshi, Goto, Masahiro, Ohta, Katsuya, Satake, Hironaga, Noura, Shingo, Kagawa, Yoshinori, Kawakami, Hisato, Hasegawa, Hiroko, Yanagihara, Kazuhiro, Shingai, Tatsushi, Nakata, Ken, Kotaka, Masahito, Hiraki, Masayuki, Konishi, Ken, Nakae, Shiro, Sakai, Daisuke, Kurokawa, Yukinori, Shimokawa, Toshio, Tsujinaka, Toshimasa, Satoh, Taroh
Publicado 2022